Design and validation of a histological scoring system for nonalcoholic fatty liver disease
暂无分享,去创建一个
O. Cummings | M. Torbenson | L. Ferrell | M. V. Van Natta | D. Kleiner | M. Yeh | A. Sanyal | M. Contos | A. McCullough | E. Brunt | C. Behling | Yao‐Chang Liu | A. Unalp‐Arida | A. Unalp‐arida | A. Mccullough | A. Unalp-arida | Cynthia E. Behling
[1] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[2] E. Roberts,et al. Steatohepatitis in children. , 2002, Best practice & research. Clinical gastroenterology.
[3] P. Giral,et al. Liver fibrosis in overweight patients. , 2000, Gastroenterology.
[4] P. Bedossa,et al. Observer variation in assessment of liver biopsies of alcoholic patients. , 1988, Alcoholism, clinical and experimental research.
[5] E. Brunt. Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.
[6] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[7] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[8] J. Everhart,et al. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. , 2003, Gastroenterology.
[9] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[10] F. Brancati,et al. The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.
[11] E. Roberts,et al. Nonalcoholic steatohepatitis in children , 2003, Current gastroenterology reports.
[12] G. Farrell. Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region? , 2003, Journal of gastroenterology and hepatology.
[13] J. Goldblum,et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[14] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[15] A. Sanyal,et al. AGA technical review on nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[16] C. Day,et al. Non‐alcoholic steatohepatitis: Definitions and pathogenesis , 2002, Journal of gastroenterology and hepatology.
[17] J. Hoofnagle,et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis , 2004, Hepatology.
[18] E. Brunt,et al. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond , 2000, Hepatology.
[19] Nash Crn. Nonalcoholic steatohepatitis clinical research network , 2003, Hepatology.
[20] A. Reuben. Child comes of age , 2002, Hepatology.
[21] A. McCullough,et al. Update on nonalcoholic fatty liver disease. , 2002, Journal of clinical gastroenterology.
[22] A. Perez-Atayde,et al. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. , 1995, The Journal of pediatrics.
[23] S. Locarnini. Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.
[24] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[25] P. Diggle. Analysis of Longitudinal Data , 1995 .
[26] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[27] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[28] B. Neuschwander‐Tetri,et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone , 2003, Hepatology.
[29] Z. Younossi,et al. Non‐alcoholic fatty liver disease: An overview , 2002, Journal of gastroenterology and hepatology.